Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative SMMT - Summit Therapeutics Inc.
28.2 M
LAST VALUE
9.32%
2 YEAR CAGR
11.75%
5 YEAR CAGR
24.17%
10 YEAR CAGR